281 related articles for article (PubMed ID: 16311108)
1. Advances in chemotherapy for patients with extremity soft tissue sarcoma.
Eilber FC; Tap WD; Nelson SD; Eckardt JJ; Eilber FR
Orthop Clin North Am; 2006 Jan; 37(1):15-22. PubMed ID: 16311108
[TBL] [Abstract][Full Text] [Related]
2. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
[TBL] [Abstract][Full Text] [Related]
3. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
5. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
Schuetze SM; Patel S
Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
[TBL] [Abstract][Full Text] [Related]
6. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemotherapy and split-course radiation therapy for patients with localized soft tissue sarcomas: home run, base hit, or strike out?
Pisters PW
J Clin Oncol; 2006 Feb; 24(4):549-51. PubMed ID: 16446327
[No Abstract] [Full Text] [Related]
8. Preoperative and postoperative chemotherapy with ifosfamide and adriamycin for adult high-grade soft-tissue sarcomas in the extremities: Japan Clinical Oncology Group Study JCOG0304.
Tanaka K; Kawamoto H; Saito I; Yoshimura K; Fukuda H; Iwamoto Y
Jpn J Clin Oncol; 2009 Apr; 39(4):271-3. PubMed ID: 19155282
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
Menendez LR; Ahlmann ER; Savage K; Cluck M; Fedenko AN
Clin Orthop Relat Res; 2007 Feb; 455():219-24. PubMed ID: 17016226
[TBL] [Abstract][Full Text] [Related]
10. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
Meric F; Hess KR; Varma DG; Hunt KK; Pisters PW; Milas KM; Patel SR; Benjamin RS; Plager C; Papadopoulos NE; Burgess MA; Pollock RE; Feig BW
Cancer; 2002 Sep; 95(5):1120-6. PubMed ID: 12209699
[TBL] [Abstract][Full Text] [Related]
11. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
Cormier JN; Huang X; Xing Y; Thall PF; Wang X; Benjamin RS; Pollock RE; Antonescu CR; Maki RG; Brennan MF; Pisters PW
J Clin Oncol; 2004 Nov; 22(22):4567-74. PubMed ID: 15542808
[TBL] [Abstract][Full Text] [Related]
12. Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas.
Comandone A; Bretti S; Bertetto O; Oliva C; Bergnolo P; Bumma C
Anticancer Res; 2000; 20(3B):2077-80. PubMed ID: 10928155
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy for soft tissue sarcoma--current concepts and review].
Umeda T; Ishii T; Hatakeyama K; Wakita H
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1937-44. PubMed ID: 8215466
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy for soft tissue sarcomas.
Mertens WC; Bramwell VH
Hematol Oncol Clin North Am; 1995 Aug; 9(4):801-15. PubMed ID: 7490242
[TBL] [Abstract][Full Text] [Related]
15. Soft tissue sarcomas of childhood.
Meyer WH; Spunt SL
Cancer Treat Rev; 2004 May; 30(3):269-80. PubMed ID: 15059650
[No Abstract] [Full Text] [Related]
16. [Adjuvant chemotherapy in soft-tissue sarcomas?].
Sauer H
Strahlenther Onkol; 1995 Apr; 171(4):185-94. PubMed ID: 7740405
[TBL] [Abstract][Full Text] [Related]
17. The management of adult soft tissue sarcomas.
Mendenhall WM; Indelicato DJ; Scarborough MT; Zlotecki RA; Gibbs CP; Mendenhall NP; Mendenhall CM; Enneking WF
Am J Clin Oncol; 2009 Aug; 32(4):436-42. PubMed ID: 19657238
[TBL] [Abstract][Full Text] [Related]
18. Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.
Nielsen OS; Reichardt P; Christensen TB; Pink D; Daugaard S; Hermans C; Marreaud S; van Glabbeke M; Blay J; Judson I
Eur J Cancer; 2006 Sep; 42(14):2303-9. PubMed ID: 16891112
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide in the treatment of soft tissue sarcomas.
Connelly EF; Budd GT
Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of advanced bone and soft tissue sarcoma].
Yamawaki S; Isu K; Ubayama Y; Yamaguti H; Gotou M
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1757-63. PubMed ID: 6541020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
